Here's Why You Should Retain Inogen Stock in Your Portfolio for Now
INGN broadens beyond portable oxygen concentrators into home respiratory care, but U.S. revenues face pressure from channel shifts.
INGN - Inogen, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$26.00
DETAILS
HIGH:
$26.00
LOW:
$26.00
MEDIAN:
$26.00
CONSENSUS:
$26.00
UPSIDE:
306.25%
Stock News
Inogen, Inc. (INGN) Q1 2026 Earnings Call Transcript
Inogen, Inc. (INGN) Q1 2026 Earnings Call Transcript
INGN Stock Dips on Q1 Earnings Miss, Sales Up Y/Y, Gross Margin Improves
Inogen posts higher Q1 revenues and improved gross margin as international portable oxygen demand offsets weaker U.S. sales.
Inogen (INGN) Reports Q1 Loss, Beats Revenue Estimates
Inogen (INGN) came out with a quarterly loss of $0.3 per share versus the Zacks Consensus Estimate of a loss of $0.24. This compares to a loss of $0.25 per share a year ago.
Inogen Announces First Quarter 2026 Financial Results
BEVERLY, Mass.--(BUSINESS WIRE)---- $INGN #AirwayClearance--Inogen Announces First Quarter 2026 Financial Results.
Inogen (NASDAQ:INGN) Stock Price Passes Above 50 Day Moving Average – Here’s What Happened
Inogen, Inc (NASDAQ: INGN - Get Free Report) shares crossed above its fifty day moving average during trading on Thursday. The stock has a fifty day moving average of $6.29 and traded as high as $7.38. Inogen shares last traded at $6.99, with a volume of 201,150 shares traded. Analyst Ratings Changes Separately, Freedom Capital
Inogen to Report First Quarter 2026 Financial Results on May 7, 2026
BEVERLY, Mass.--(BUSINESS WIRE)---- $INGN #AirwayClearance--Inogen to Report First Quarter 2026 Financial Results on May 7, 2026.
Here's Why You Should Retain Inogen Stock in Your Portfolio for Now
INGN rides surging POC demand and global growth tailwinds, but U.S. channel shifts and macro risks may weigh on near-term performance.
Inogen (INGN) Surges 6.9%: Is This an Indication of Further Gains?
Inogen (INGN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Inogen Announces the Appointment of Vafa Jamali to Board of Directors
BEVERLY, Mass.--(BUSINESS WIRE)---- $INGN #AirwayClearance--Inogen Announces the Appointment of Vafa Jamali to Board of Directors.
Inogen Announces Participation in the 25th Annual Needham Virtual Healthcare Conference
BEVERLY, Mass.--(BUSINESS WIRE)---- $INGN #AirwayClearance--Inogen Announces Participation in the 25th Annual Needham Virtual Healthcare Conference.
Inogen, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BEVERLY, Mass.--(BUSINESS WIRE)---- $INGN #AirwayClearance--Inogen, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).
Inogen Announces Leadership Appointments Designed to Accelerate Next Phase of Growth
BEVERLY, Mass.--(BUSINESS WIRE)---- $INGN #AirwayClearance--Inogen Announces Leadership Appointments Designed to Accelerate Next Phase of Growth.
Inogen (INGN) Up 6.8% Since Last Earnings Report: Can It Continue?
Inogen (INGN) reported earnings 30 days ago. What's next for the stock?
Inogen (NASDAQ:INGN) Stock Price Crosses Below Two Hundred Day Moving Average – Should You Sell?
Inogen, Inc (NASDAQ: INGN - Get Free Report) passed below its two hundred day moving average during trading on Wednesday. The stock has a two hundred day moving average of $7.17 and traded as low as $6.15. Inogen shares last traded at $6.23, with a volume of 194,339 shares trading hands. Analyst Ratings Changes Separately,
Inogen Announces Participation in the KeyBanc Virtual Life Sciences & MedTech Investor Forum
BEVERLY, Mass.--(BUSINESS WIRE)---- $INGN #AirwayClearance--Inogen Announces Participation in the KeyBanc Virtual Life Sciences & MedTech Investor Forum.
Inogen Stock Dips Despite Q4 Earnings Beat, Revenues Up Y/Y
INGN posts narrower Q4 loss and 2% revenue rise, but shares dip as U.S. sales and rentals weaken despite international strength.
Inogen, Inc. (INGN) Q4 2025 Earnings Call Transcript
Inogen, Inc. (INGN) Q4 2025 Earnings Call Transcript
Inogen (INGN) Reports Q4 Loss, Misses Revenue Estimates
Inogen (INGN) came out with a quarterly loss of $0.26 per share versus the Zacks Consensus Estimate of a loss of $0.36. This compares to a loss of $0.41 per share a year ago.
Inogen Announces Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Outlook
BEVERLY, Mass.--(BUSINESS WIRE)---- $INGN #AirwayClearance--Inogen Announces Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Outlook.